{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-042870","form_type":"8-K","ticker":"CLRB","cik":"0001279704","company_name":"Cellectar Biosciences, Inc.","filed_at":"2025-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.823434+00:00","generated_at":"2026-05-22T23:52:16.759996+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cellectar Biosciences to explore strategic alternatives; hires Oppenheimer as advisor","bullets":["Board authorized exploration of M&A, partnerships, licensing or other transactions; no deal reached.","Oppenheimer & Co. retained as exclusive financial advisor for the strategic evaluation process.","CEO James Caruso cites need for a partner to develop lead asset iopofosine I-131 and pipeline.","Alpha- and Auger-emitting radioconjugates CLR 225 and CLR 125 in solid tumors are additional opportunities.","No timetable set; company will not update progress unless a definitive agreement is reached."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-042870","json":"https://secwatch.observer/filing/0001104659-25-042870.json","markdown":"https://secwatch.observer/filing/0001104659-25-042870.md","text":"https://secwatch.observer/filing/0001104659-25-042870.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925042870/0001104659-25-042870-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925042870/tm2513754d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T23:52:16.759996+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}